Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD45 Antibody (OX-1), DyLight 680, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB10064895FR
Description
CD45 Monoclonal specifically detects CD45 in Rat, S. pneumoniae samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen.Specifications
CD45 | |
Monoclonal | |
DyLight 680 | |
B220, CD45 antigen, CD45R, EC 3.1.3.48, L-CA, LY5, protein tyrosine phosphatase, receptor type, C, receptor-type tyrosine-protein phosphatase C, T200 glycoprotein, T200 leukocyte common antigen, T200receptor type, c polypeptide | |
Mouse | |
Protein G purified | |
RUO | |
Primary | |
NB100-64895 recognises CD45, also known as the leucocyte common antigen (LCA). The leucocyte common antigen consists of a family of heavily glycosylated membrane glycoproteins of molecular weight 180. | |
Store at 4C in the dark. | |
IgG1 |
Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Frozen) | |
OX-1 | |
Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen | |
PTPRC | |
A 100kD thymocyte glycoprotein fraction enriched for the rat leukocyte common antigen (L-CA). | |
0.25 mL | |
Adaptive Immunity, Cell Biology, Cellular Markers, Cytokine Research, Glia Markers, Hematopoietic Stem Cell Markers, Immunology, MAP Kinase Signaling, Mast Cell Markers, Mesenchymal Stem Cell Markers, Microglia Markers, Modulation of DNA Pools, Myeloid Cell Markers, Neurodegeneration, Neuronal Cell Markers, Neuroscience, Signal Transduction, Stem Cell Markers | |
5788 | |
Rat, Streptococcus species | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction